Early T-cell responses in tuberculosis immunity

Immunological Reviews

Volumn 225, Issue 1, 2008, Pages 284-299

  Winslow, Gary M ^a,b   Cooper, Andrea ^b   Reiley, William ^b   Chatterjee, Madhumouli ^a   Woodland, David L ^b  

^a WADSWORTH CENTER   (United States)

^b TRUDEAU INSTITUTE   (United States)

Author keywords

Immunity; Mycobacteria; T cells

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BETA 2 MICROGLOBULIN; CD69 ANTIGEN; DENDRITIC CELL SPECIFIC INTERCELLULAR ADHESION MOLECULE 3 GRABBING NON INTEGRIN; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYCOBACTERIUM VACCINE; PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; BACTERIAL IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLONY FORMING UNIT; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; EXPERIMENTAL MODEL; INNATE IMMUNITY; LUNG GRANULOMA; MACROPHAGE; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REINFECTION; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TRANSGENIC MOUSE; TUBERCULOSIS; VACCINATION;

ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 52049087783     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2008.00693.x     Document Type: Review

References (166)

1. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva, Switzerland : World Health Organization, 2007.
2. Raviglione MC, Smith IM. XDR tuberculosis - implications for global public health. N Engl J Med 2007 356 : 656 659.
3. Andersen P. Tuberculosis vaccines - an update. Nat Rev Microbiol 2007 5 : 484 487.
4. Young D, Dye C. The development and impact of tuberculosis vaccines. Cell 2006 124 : 683 687.
5. Kaufmann SH. Envisioning future strategies for vaccination against tuberculosis. Nat Rev Immunol 2006 6 : 699 704.
6. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999 282 : 677 686.
7. Verma RK, Jain A. Antibodies to mycobacterial antigens for diagnosis of tuberculosis. FEMS Immunol Med Microbiol 2007 51 : 453 461.
8. Scriba TJ, et al. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 2008 180 : 1962 1970.
9. Giacomini E, et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001 166 : 7033 7041.
10. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993 17 : 968 975.
11. Andersen P, Doherty TM. The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005 3 : 656 662.
12. Soares AP, et al. Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 2008 180 : 3569 3577.
13. Smith SM, et al. Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol 2000 165 : 7088 7095.
14. Tully G, et al. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J Immunol 2005 174 : 2174 2184.
15. Ordway D, et al. The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig. J Immunol 2007 179 : 2532 2541.
16. Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 2002 17 : 693 702.
17. Lewinsohn DM, et al. High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque. Microbes Infect 2006 8 : 2587 2598.
18. Chege GK, Williamson AL, Passmore JS, Bourn W, Ryffel B, Shephard EG. The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research. Vaccine 2005 23 : 5783 5791.
19. Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, Germain RN. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 2008 28 : 271 284.
20. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004 22 : 599 623.
21. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001 19 : 93 129.
22. Turner J, et al. Immunological basis for reactivation of tuberculosis in mice. Infect Immun 2001 69 : 3264 3270.
23. Medina E, North RJ. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 1998 93 : 270 274.
24. Fortin A, Abel L, Casanova JL, Gros P. Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. Annu Rev Genom Hum Genet 2007 8 : 163 192.
25. Hill AV. Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 2006 40 : 469 486.
26. Lyadova IV, et al. Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease. J Immunol 2000 165 : 5921 5231.
27. Orme IM, Collins FM. Aerogenic vaccination of mice with Mycobacterium bovis BCG. Tubercle 1986 67 : 133 140.
28. Orme IM, Collins FM. Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes. J Exp Med 1986 163 : 203 208.
29. Cardona PJ, et al. The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand J Immunol 1999 49 : 362 366.
30. North RJ, LaCourse R, Ryan L. Vaccinated mice remain more susceptible to Mycobacterium tuberculosis infection initiated via the respiratory route than via the intravenous route. Infect Immun 1999 67 : 2010 2012.
31. Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 1997 78 : 57 66.
32. North RJ. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J Infect Dis 1995 172 : 1550 1553.
33. Ernst JD. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 1998 66 : 1277 1281.
34. Neyrolles O, Gicquel B, Quintana-Murci L. Towards a crucial role for DC-SIGN in tuberculosis and beyond. Trends Microbiol 2006 14 : 383 387.
35. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995 155 : 5343 5351.
36. Leemans JC, et al. Macrophages play a dual role during pulmonary tuberculosis in mice. J Infect Dis 2005 191 : 65 74.
37. Rivas-Santiago B, et al. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect Immun 2008 76 : 935 941.
38. Heldwein KA, Fenton MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect 2002 4 : 937 944.
39. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005 202 : 1715 1724.
40. Edwards AD, et al. Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic. J Immunol 2002 169 : 3652 3660.
41. Pompei L, et al. Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tuberculosis is due to use of distinct TLRs. J Immunol 2007 178 : 5192 5199.
42. Reiling N, et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002 169 : 3480 3484.
43. Jang S, Uematsu S, Akira S, Salgame P. IL-6 and IL-10 induction from dendritic cells in response to Mycobacterium tuberculosis is predominantly dependent on TLR2-mediated recognition. J Immunol 2004 173 : 3392 3397.
44. Bhatt K, Salgame P. Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 2007 27 : 347 362.
45. Pathak SK, et al. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol 2007 8 : 610 618.
46. Algood HM, Lin PL, Yankura D, Jones A, Chan J, Flynn JL. TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection. J Immunol 2004 172 : 6846 6857.
47. Orme IM CA. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999 20 : 307 312.
48. Rhoades E, Cooper A, Orme I. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun 1995 63 : 3871 3877.
49. Geijtenbeek TB, et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003 197 : 7 17.
50. Tailleux L, et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003 197 : 121 127.
51. Tian T, Woodworth J, Skold M, Behar SM. In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J Immunol 2005 175 : 3268 3272.
52. Wolf AJ, et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 2007 179 : 2509 2519.
53. Dunn PL, North RJ. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect Immun 1995 63 : 3428 3237.
54. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2001 193 : 271 280.
55. Orme IM, Collins FM. Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell Immunol 1984 84 : 113 120.
56. North RJ. Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. Cell Immunol 1973 7 : 166 176.
57. Lefford MJ. Transfer of adoptive immunity to tuberculosis in mice. Infect Immun 1975 11 : 1174 1181.
58. Raupach B, Kaufmann SH. Immune responses to intracellular bacteria. Curr Opin Immunol 2001 13 : 417 428.
59. Ladel CH, Daugelat S, Kaufmann SH. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur J Immunol 1995 25 : 377 384.
60. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 1999 162 : 5407 5416.
61. + T cells. Infect Immun 1987 55 : 2037 2041.
62. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med 1993 178 : 2243 2247.
63. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993 178 : 2249 2254.
64. Pearl JE, Saunders B, Ehlers S, Orme IM, Cooper AM. Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma- deficient mouse. Cell Immunol 2001 211 : 43 50.
65. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995 63 : 736 740.
66. Dalton DK, Pitts-Meek S, Keshav TA, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993 259 : 1739 1742.
67. Cowley SC, Elkins KL. CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J Immunol 2003 171 : 4689 4699.
68. Lande R, et al. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol 2003 170 : 1174 1182.
69. Fortune SM, et al. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol 2004 172 : 6272 6280.
70. Gehring AJ, Rojas RE, Canaday DH, Lakey DL, Harding CV, Boom WH. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect Immun 2003 71 : 4487 4497.
71. Ting LM, Kim AC, Cattamanchi A, Ernst JD. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J Immunol 1999 163 : 3898 3906.
72. Woodworth JS, Behar SM. Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. Crit Rev Immunol 2006 26 : 317 352.
73. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992 89 : 12013 12017.
74. Turner J, et al. CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am J Respir Cell Mol Biol 2001 24 : 203 209.
75. D'Souza CD, et al. A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am J Respir Cell Mol Biol 2000 23 : 188 193.
76. Sousa AO, et al. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci USA 2000 97 : 4204 4208.
77. Orme IM. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol 1987 138 : 293 298.
78. Schaible UE, Collins HL, Priem F, Kaufmann SHE. Correction of the iron overload defect in {beta}-2-Microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 2002 196 : 1507 1513.
79. Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. Susceptibility of mice deficient in CD1d or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 1999 189 : 1973 1980.
80. Urdahl KB, Liggitt D, Bevan MJ. CD8+T Cells accumulate in the lungs of Mycobacterium tuberculosis-infected Kb-/-Db-/- Mice, but provide minimal protection. J Immunol 2003 170 : 1987 1994.
81. Serbina NV, Flynn JL. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun 1999 67 : 3980 3988.
82. Serbina NV, Liu CC, Scanga CA, Flynn JL. CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. J Immunol 2000 165 : 353 363.
83. Kamath AB, Woodworth J, Xiong X, Taylor C, Weng Y, Behar SM. Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J Exp Med 2004 200 : 1479 1489.
84. Orme IM, et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol 1992 148 : 189 196.
85. Winau F, et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006 24 : 105 117.
86. Griffin JP, Orme IM. Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis. Infect Immun 1994 62 : 1683 1690.
87. Andersen P, Askgaard D, Ljungqvist L, Bentzon MW, Heron I. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 1991 59 : 1558 1563.
88. Haslov K, Andersen A, Nagai S, Gottschau A, Sorensen T, Andersen P. Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun 1995 63 : 804 810.
89. Lewinsohn DA, et al. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS pathogens 2007 3 : 1240 1249.
90. Andersen P, Askgaard D, Gottschau A, Bennedsen J, Nagai S, Heron I. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immunol 1992 36 : 823 831.
91. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995 63 : 1710 1717.
92. Andersen P. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 1997 45 : 115 131.
93. Moody DB, Sugita M, Peters PJ, Brenner MB, Porcelli SA. The CD1-restricted T-cell response to mycobacteria. Res Immunol 1996 147 : 550 559.
94. Jayawardena-Wolf J, Bendelac A. CD1 and lipid antigens: intracellular pathways for antigen presentation. Curr Opin Immunol 2001 13 : 109 113.
95. Orme IM. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun 1988 56 : 3310 3312.
96. Shen H, Miller JF, Fan X, Kolwyck D, Ahmed R, Harty JT. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell 1998 92 : 535 545.
97. Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 1991 59 : 1905 1910.
98. Rook GA, Steele J, Barnass S, Mace J, Stanford JL. Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin Exp Immunol 1986 63 : 105 110.
99. Havlir DV, Wallis RS, Boom WH, Daniel TM, Chervenak K, Ellner JJ. Human immune response to Mycobacterium tuberculosis antigens. Infect Immun 1991 59 : 665 670.
100. Orme IM, et al. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol 1992 148 : 189 196.
101. Roberts AD, et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 1995 85 : 502 508.
102. Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993 151 : 518 525.
103. Yanagisawa S, Koike M, Kariyone A, Nagai S, Takatsu K. Mapping of V beta 11+helper T cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis. Int Immunol 1997 9 : 227 237.
104. Pais TF, Silva RA, Smedegaard B, Appelberg R, Andersen P. Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection. Immunology 1998 95 : 69 75.
105. Wiker HG, Harboe M. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 1992 56 : 648 661.
106. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 1997 276 : 1420 1422.
107. Kariyone A, et al. Identification of amino acid residues of the T-cell epitope of Mycobacterium tuberculosis alpha antigen critical for Vbeta11(+) Th1 cells. Infect Immun 1999 67 : 4312 4319.
108. Ulrichs T, Anding P, Porcelli S, Kaufmann SH, Munk ME. Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect Immun 2000 68 : 6073 6076.
109. Olsen AW, Hansen PR, Holm A, Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 2000 30 : 1724 1732.
110. Pym AS, et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003 9 : 533 539.
111. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996 64 : 16 22.
112. Blythe MJ, et al. An analysis of the epitope knowledge related to Mycobacteria. Immunome Res 2007 3 : 10.
113. Rogerson BJ, Jung YJ, LaCourse R, Ryan L, Enright N, North RJ. Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice. Immunology 2006 118 : 195 201.
114. Winslow GM, Roberts AD, Blackman MA, Woodland DL. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J Immunol 2003 170 : 2046 2052.
115. Chackerian AA, Perera TV, Behar SM. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect Immun 2001 69 : 2666 2674.
116. Lazarevic V, Nolt D, Flynn JL. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J Immunol 2005 175 : 1107 1117.
117. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 1998 8 : 683 691.
118. Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun 2002 70 : 4501 4509.
119. Majlessi L, Rojas MJ, Brodin P, Leclerc C. CD8+ T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. Infect Immun 2003 71 : 7173 7177.
120. Irwin SM, et al. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun 2005 73 : 5809 5816.
121. Lawrence CW, Braciale TJ. Activation, differentiation, and migration of naive virus-specific CD8+T cells during pulmonary influenza virus infection. J Immunol 2004 173 : 1209 1218.
122. Zimmermann C, Prevost-Blondel A, Blaser C, Pircher H. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur J Immunol 1999 29 : 284 290.
123. Busch DH, Pilip IM, Vijh S, Pamer EG. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998 8 : 353 362.
124. Mercado R, Vijh S, Allen SE, Kerksiek K, Pilip IM, Pamer EG. Early programming of T cell populations responding to bacterial infection. J Immunol 2000 165 : 6833 6839.
125. Corbin GA, Harty JT. Duration of infection and antigen display have minimal influence on the kinetics of the CD4+ T cell response to Listeria monocytogenes infection. J Immunol 2004 173 : 5679 5687.
126. Cooper AM, Callahan JE, Keen M, Belisle JT, Orme IM. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuber Lung Dis 1997 78 : 67 73.
127. Jung YJ, Lacourse R, Ryan L, North RJ. Immunization against airborne tuberculosis by an earlier primary response to a concurrent intravenous infection. Immunology 2008 124 : 514 521.
128. van Faassen H, Dudani R, Krishnan L, Sad S. Prolonged antigen presentation, APC-, and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes. J Immunol 2004 172 : 3491 3500.
129. Demotz S, Grey HM, Sette A. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 1990 249 : 1028 1030.
130. Tobian AA, et al. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J Immunol 2003 171 : 1413 1422.
131. Pai RK, Convery M, Hamilton TA, Boom WH, Harding CV. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immunol 2003 171 : 175 184.
132. Noss EH, Harding CV, Boom WH. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell Immunol 2000 201 : 63 74.
133. Khader SA, et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med 2006 203 : 1805 1815.
134. Mempel TR, Henrickson SE, Von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004 427 : 154 159.
135. Bousso P, Robey E. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat Immunol 2003 4 : 579 585.
136. Miller MJ, Hejazi AS, Wei SH, Cahalan MD, Parker I. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc Natl Acad Sci USA 2004 101 : 998 1003.
137. Busch DH, Pamer EG. T cell affinity maturation by selective expansion during infection. J Exp Med 1999 189 : 701 710.
138. Rees W, et al. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci USA 1999 96 : 9781 9786.
139. Testi R, Phillips JH, Lanier LL. T cell activation via Leu-23 (CD69). J Immunol 1989 143 : 1123 1128.
140. Shiow LR, et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006 440 : 540 544.
141. Stockinger B, Bourgeois C, Kassiotis G. CD4+ memory T cells: functional differentiation and homeostasis. Immunol Rev 2006 211 : 39 48.
142. Hataye J, Moon JJ, Khoruts A, Reilly C, Jenkins MK. Naive and memory CD4+ T cell survival controlled by clonal abundance. Science 2006 312 : 114 116.
143. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T-cell immunity and peripheral tolerance induction in vivo. Immunity 1994 1 : 327 339.
144. Garside P, et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998 281 : 96 99.
145. Badovinac VP, Haring JS, Harty JT. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity 2007 26 : 827 841.
146. Wolf AJ, et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 2008 205 : 105 115.
147. Tamura T, et al. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model. Int Immunol 2004 16 : 1691 1699.
148. Anis MM, Fulton SA, Reba SM, Harding CV, Boom WH. Modulation of naive CD4+ T-cell responses to an airway antigen during pulmonary mycobacterial infection. Infect Immun 2007 75 : 2260 2268.
149. Reiley WW, Calayag MD, Wittmer ST, Huntington JL, Pearl JE, Fountain JJ, et al. ESAT-6-specific CD4 T cell responses to aerosol M. tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci USA 2008 105 : 10961 10966.
150. Gonzalez-Juarrero M, Turner OC, Turner J, Marietta P, Brooks JV, Orme IM. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect Immun 2001 69 : 1722 1728.
151. Pedroza-Gonzalez A, et al. In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent Mycobacterium tuberculosis. Int J Exp Pathol 2004 85 : 135 145.
152. Jung YJ, Ryan L, Lacourse R, North RJ. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2005 201 : 1915 1924.
153. Kahnert A, Hopken UE, Stein M, Bandermann S, Lipp M, Kaufmann SH. Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs. J Infect Dis 2007 195 : 46 54.
154. Ulrichs T, et al. Human tuberculosis granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J Pathol 2004 204 : 217 228.
155. Kapina MA, et al. CD27 low CD4 T lymphocytes that accumulate in the mouse lungs during mycobacterial infection differentiate from CD27 high precursors in situ, produce IFN-γ, and protect the host against tuberculosis infection. J Immunol 2007 178 : 976 985.
156. Scott-Browne JP, et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 2007 204 : 2159 2169.
157. Kursar M, et al. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 2007 178 : 2661 2665.
158. Serbina NV, Flynn JL. CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect Immun 2001 69 : 4320 4328.
159. Terszowski G, et al. Evidence for a functional second thymus in mice. Science 2006 312 : 284 287.
160. Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, Hill AV. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 2003 171 : 1602 1609.
161. Beveridge NE, et al. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol 2007 37 : 3089 3100.
162. Khader SA, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007 8 : 369 377.
163. Chiang CY, Riley LW. Exogenous reinfection in tuberculosis. Lancet Infect Dis 2005 5 : 629 636.
164. Kaufmann SH. Is the development of a new tuberculosis vaccine possible? Nat Med 2000 6 : 955 960.
165. Orme IM. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 1988 140 : 3589 3593.
166. Kamath A, Woodworth JS, Behar SM. Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection. J Immunol 2006 177 : 6361 6369.